Patients facing medical decisions often find themselves drowning in confusing information that is laden with scientific terminology and often neglects the human element. Keith Berelowitz, a clinical research operations veteran motivated by personal experience, created the Trialport platform to embed trial information in patient community websites with plain language, multilingual support, and behavioral assessments that go beyond medical eligibility. The company partners with patient advocacy groups while providing sponsors with real-time behavioral insights that reveal how patients engage with trial information. Berelowitz, founder and CEO of Trialport, discusses his vision for a future where clinical trials are discussed alongside standard of care as a routine healthcare option, the gap between clinical trial availability and patient awareness, and how the Trialport platform works to help both patients and sponsors understand readiness for clinical trials.

Stay Connected
Sign up for updates straight to your inbox.
